What are the risks of genetic engineering in humans? (human genetic engineering)

Human Genetic EngineeringIntentional germline genetic engineering in humans where the DNA changes will be inherited by successive generations is by far the biggest and most profound risk in genetic engineering. The "Center for Genetics and Society" states it this way. "We are fast approaching arguably the most consequential technological threshold in all of human history: the ability to alter the

What are the benefits of human genetic engineering? (human genetic engineering)

Human Genetic EngineeringThe benefits of human genetic engineering can be found in the headlines nearly every day. With the successful cloning of mammals and the completion of the Human Genome Project, scientists all over the world are aggressively researching the many different facets of human genetic engineering. These continuing breakthroughs have allowed science to more deeply understand DNA

Genetic Engineering – Ethics and Controversy

Genetic Engineering Ethics

Genetic Engineering - Stem Cell Research Ethics and Controversy

ISSUE'S AND CONTROVERSY

Stem Cell research is a highly controversial and emotive subject that is, more often that not, misunderstood, misrepresented and fraught with 'ifs and buts'. There are fears that science is moving too fast without giving proper consideration to potential impacts and to ethical concerns. The subject is a confusing and complex one that is difficult to grasp and constantly changing. Governments around the world struggle to develop policies and guidelines at the same time as individuals struggle with their conscience and beliefs.

There are two key areas of debate:

The scientific debate; what is proven, what is debatably proven, research results that are received with skepticism.

The ethical/moral debate; some people base their objections on religious beliefs, some on ethical grounds, others believe simply, that changing or 'messing with' the human genome is simply not right, against nature and a highly dangerous path to follow. Others harbour concerns about the directions in which stem cell research can be taken.

Significantly much of the debate is held at an emotional level with scientific facts often overlooked or conveniently ignored. So with that in mind lets first look at the issues that are currently facing scientist in the field.

Exciting claims are regularly reported by scientists with their findings published in reputable science journals with all the relevant data and background information, the media, picking up on these stories, repackages the findings for public consumption and dutifully supplies the splash headline:

'Brain stem cells to cure diabetes'
'Giant leap for the 'secret of long life'

Unfortunately the fine detail is the thing that is often lost leading to much misconception, once you get to the small print you discover that all is not as it seems. Sentences like 'hold much promise', 'seems to suggest', 'has the exciting potential to be', 'it is reasonable to assume' abound in reports of advances in genetic engineering and stem cell research.

WHAT ARE SOME OF THE SCIENTIFIC HURDLES STILL TO BE OVERCOME?

As rapidly as the field of stem cell research is developing new questions and problems arise, with each new discovery another set of problems seems to arrive. Scientist really don't fully understand why embryonic stem cells can proliferate successfully in the laboratory without differentiating but adult stem cells are not so easily controlled or proliferated. As yet there is no reliable and reproducible way to create stem cell lines. For experimentation to continue successfully it is essential that results can be reproduced repeatedly, at present this simply doesn't happen. Scientists have yet to agree a set of test to confirm that the fundamental properties of a stem cell exists in a set of laboratory stem cells. Even the test that are used are not wholly reliable and accurate.

In actuality scientist don't really know exactly how the process of stem cell differentiation takes place, whether the stem cell be embryonic or adult. Differentiation occurs when a stem cell becomes a specific cell type, this happens when the stem cell receives signals telling it to start to become a cell. Scientists barely know what those signals are and how they affect the process. Directing the differentiation of stem cells has developed over the years but is still not an wholly exact science. It seems likely the process relies on a series of complex interactions. Controlling the differentiation is proving to be a major difficulty, how to make a stem cell become the exact cell type you want is not so easy and certainly not reliably reproducible in all areas.

Scientist simply don't know how many different types of adult stem cells exist and where they exist. They also don't know how adult stem cells come to exist or how they know where to go to do their repair and replacement functions. The question of just how flexible different adult stem cell types are is still unknown. Some scientist claim that adult stem cells can differentiate into many kinds of cells outside of their specialism, others argue that this is a fluke of the laboratory.

One of the major goals for scientists is to develop a way to use stem cells to repair damaged tissue. To do this they require a large amount of cells. Embryonic stem cells are the easiest to proliferate but are not a genetic match for the patient, adult stem cells are a match but are not easy to grow or control in large numbers. The recent announcement from Seoul University is being seen as a major step forward in this area.

There are many other problems that face the scientists; the laboratory process requires the use of some animal products that leave residue, how long a laboratory created cell survives in a human is an unknown. There has been significant progress in the field but there are still many unanswered questions.

THE ETHICAL DEBATE

The biggest problem with the ethical debate is that the potential for stem cell research to produce cures for some of the worlds most deadly and debilitating diseases is pitted against fervently and deeply held moral and faith based beliefs.

The issue that gets the most attention and is often the focus for opponents of stem cell research is the use of embryonic stem cells. This is because during the process of stem cell line creation the embryo is destroyed, opponents argue that this is the taking of human life - murder. Opponents argue that, as every embryo has the potential to become a human being that each and every one is sacrosanct. Proponents argue that even under natural conditions not all embryos go on to form a baby, that unused harvested embryos would anyway be destroyed and that, ultimately the ends justify the means. Many opponents of Embryonic stem cell research put forward compelling arguments for more vigorous experimentation and research into the use of Adult stem cells. They see this as an answer to the dilemma of the potential for disease relief. In reality this debate is quite clear cut, either you believe that embryonic stem cell research is fundamentally wrong because it destroys a potential human or you believe embryonic stem cell research is acceptable because the embryo will never become a human even if it has the potential to do so.

But this argument is merely a very vocal, media fed argument that only scratches at the surface of far deeper and potentially more impactful debates. There are big questions regarding the potential directions in which stem cell research can be taken; designer babies and eugenics, cloning, chimera. What of the rights of the women who donate their eggs for research and just how much attention is being paid to the health risks? What are the potential impacts of research on the future?

CHIMERA

A chimera is an organism constructed out of living parts from more than one biological species. Many scientist see the creation of chimera as a useful tool for the observation of stem cell behaviour.

The Science

The use of chimera is seen as a way to overcome some of the hurdles outlined above. Basically it allows the scientist to test what happens when stem cells are introduced into a patient, without experimenting on humans. For experimentation purposes what happens is that human stem cells are implanted into an animal host, either an animal embryo or an adult animal. Most commonly used are mice and monkeys. Some of the experiments that have been done already involve implanting brain cells and creating mice with entire human immune systems. It is also worth noting that this is not an entirely new idea and that human-animal chimera also exist in the form of animal tissue implanted into humans; pig heart valves are commonly used as replacement organs for people with heart disease. The extent to which the implanted human stem cells affect the host animal is dependent on the stage at which the material is introduced. If the human stem cells are introduced into an early stage animal embryo then they have a much more profound effect because the stem cells of the host are less differentiated. If the stem cells are introduced into an adult animal the effect, in theory is much less profound because much less differentiation is taking place so the stem cells are more of an addition. But just how far should we go with the use of chimera? Where should the boundaries be drawn? When does the 'yuck' factor kick in?

The Ethics

The 'yuck factor' is the point at which our reaction to a piece of information or something we see makes us squirm. If we see a monkey running around a cage, we're unlikely to squirm even if we know that a percentage of that monkeys brain is made up of human cells. But what if we saw a sheep with human feet? Although there is no proof that this has happened, it is theoretically possible. In fact there are a lot of theoretically possible outcomes of chimeric experimentation and many of them may not be so evident to the naked eye. It is the mixing of animal and human cells that concerns the ethicists that have bothered to notice this element of stem cell research. For example how human would a monkey with 20% human cells be, is it human or monkey? Some might say that 20% human cells does not make a monkey human but where is the line to be drawn? These are some of the issues that the bioethicists are fighting with.

For more information on the chimera debate a good starting point is The Other Stem-Cell Debate

For a Christian Perspective: The Stuart Little Syndrome
CLONING

There are two basic types of cloning Reproductive cloning and Research cloning. Reproductive cloning means to recreate a genetic duplicate of a human being and in itself raise a great many ethical issues, therefore it is dealt with separately on this site. Research cloning is the use of cloning techniques to create an embryo for research purposes only.

The Science

The technique can be used to produce stem cells for research. The technique used is called Somatic Cell Nuclear Transfer: SCNT, what happens is that nucleus from a body cell is transplant into an egg. Using electricity or chemicals this entity is triggered into producing an embryo. The resulting embryo can then be used to obtain embryonic stem cells. This process is also know as embryo cloning or therapeutic cloning. Some of the uses for this technique include producing patient specific stem cells, the genetic material of the patient is implanted into a donor egg thus producing stem cells that are a genetic match for the patient. This stem cells could then be used for therapeutic cell transplant. Another proposed use is that stem cells could be created with genetic disorders allowing research of that disorder to be carried out. There are however a few scientific problems; the cost of therapeutic patient specific cell production may make it a non-starter or at least only available to the very rich; the very specificness of the cells means that they can only be given to the patient they were grown for, unlike conventional drugs which can be given to almost anyone. Even though recent research has improved the efficiency of cell line production it still takes a lot of time and eggs to produce very few usable lines. Also lets be clear the technique is still only useful for research purposes and there are many hurdles to be overcome before any real human use is possible.

The Ethics

Lets not forget that cloning in itself uses human embryos whether created using the in vitro fertilization method or using donated eggs, so already we have the ethical difficulties previously outlined. But there are yet more ethical problems arising out of cloning cells. There are fears that research cloning will open the door to human cloning. With the proliferation of cloned embryos the chances of a few hundred embryos going astray becomes more possible. One of the major concerns is the treatment of the women who donate their eggs. How informed is the consent they give?

THE DONORS

Whichever method is used to obtain stem cells at some point or other an egg is needed. Adult stem cells are near to impossible to proliferate outside of an egg, embryonic stem cells are taken from an embryo. So a donor is needed; enter the women. Eggs are often donated by women who seek fertility treatment, they give their spare eggs to science. Some women are paid to produce eggs for research. As far as it is know all women give 'informed' consent for the eggs to be taken. But there are big questions being asked as to exactly how informed that consent actually is.

The Science

Cloning and stem cell production requires an enormous amount of eggs. Initial attempts at cloning needed 242 eggs to produce a single usable embryonic line, since then that figure has been reduced to 20 eggs for one embryonic line. During a normal cycle a woman produces just one egg so inevitably women are treated with drugs to stimulate multiple egg production. The process requires a two stage drug programme, firstly to shut down the ovaries and then to stimulate them to produce the eggs. A woman treated with drugs to stimulate multiple egg production can produce about 10 eggs.

The Ethics

At its simplest the procedure for egg extraction is painful and invasive. However the drugs used to stimulate multiple egg production can produce serious health risks. Whilst most women suffer only minor symptoms such as headaches or nausea some can develop much serious problems such as severe ovarian hyperstimulation syndrome, which can lead to dangerous fluid buildup, clotting disorders, renal failure, infertility and even death. One drug that is used in the procedure is called Lupron (leuprolide acetate) a drug that is not approved or tested for this purpose, although it is being legally used because it is approved for other purposes. Lupron has caused many problems which have been reported to the US Food and Drug Administration (FDA) including chest pain, nausea, depression, emotional instability, loss of libido (sex drive), amblyopia (dimness of vision), syncope (fainting), asthenia (weakness), asthenia gravis hypophyseogenea (severe weakness due to loss of pituitary function), amnesia (disturbance in memory), hypertension (high arterial blood pressure).

A woman who donates spare eggs from fertility treatment has a clear motive for wanting to undertake such a procedure, she wants a baby. However those choosing to voluntarily donate eggs will have different motivations; possibly they believe they are helping to find ways to cure disease, but how many realise just how far into the future those cures are? Maybe they are doing it for the money, tho' laws exist preventing excessive payments in some countries, in other poorer countries that money can be more than useful, but how aware are the women of the risks they are taking ?

EUGENICS AND DESIGNER BABIES

There are issues associated with the connections between stem cell research, eugenics and designer babies. It is within the area of stem cell research that information will be found that will enable scientists to pursue eugenics, the betterment of humanity and the ability for parents to choose not only the sex but also physical and character traits of their offspring, designer babies. Because these are such big issues they are covered elsewhere on this site.

Genetic Engineering Ethics

Genetic Engineering Ethics In Science Fiction

Genetic Engineering Ethics

Q: I am a final year university student who is currently writing an ethics essay. I have been trying to put forward the view that some of the ethical problems associated with new technology have already been explored in science fiction. I would like help in substantiating this view. My essay is on the topic of human genetic engineering and cloning. While I am familiar with some of the work on this topic I was hoping for some help in tracking down some short stories or novels which deal with either the ethical problems or the social implications of these topics. At the moment my list includes Hyperion Quartet by Dan Simmons Glory Season by David Brin Some parts of the Uplift books by David Brin As you can see this is rather short and mostly deals with the social consequences rather than the ethics. Does anyone have any suggestions? I would appreciate any recommendations (along with magazine titles and editions for short stories if possible) I am also interested in peoples opinions on the idea that science fiction is the ideal medium for exploring tomorrows ethical dilemmas.

A: -Greg Egan, definitely. Egan mostly seems to be interested in the boundary between ontology and the more speculative aspects of physics. I find that a bit of a shame, because I don't think it's his real strength. Anyone can wave their hands about the Copenhagen Interpretation, but nobody is better than Egan at writing about the ethical and social implications of advanced biotechnology. I'd start with _Distress_. The first chapter is stunning, but you should pay close attention to the whole book. Don't miss the voluntary autists, the asexes, the notion of targeted biowarfare, and the ethical implications of the way that bioengineering interacts with intellectual property law. -Most of the Lois McMaster Bujold books have some facet of genegineering ethics conundrums. I especially recommend Memory and the last one "A Civil Campaign" in which a conniving aristocrat creates 180 daughters of himself and ova that have been deposited in the local gene bank. Memory deals with a set of clones and how they become enmeshed in a web of mistaken identity and amnesia. Another one is "Falling Free" in which a corporation creates a new "race" of mankind that has four arms and no legs for work in freefall.

Genetic Engineering Ethics

Human Genetic Engineering – Background

Human Genetic EngineeringResearchers are currently trying to map out and assign genes to different body functions and diseases. Once the genes responsible for a disease are found, theoretically gene therapy should be able to permanently cure the disease. Interactions between genes and gene regulators are complex and many of these interactions are currently unknown.Human Genetic Engineering

Human Genetic Engineering – History

Human Genetic EngineeringThe first gene therapy trials on humans began in 1990 on patients with Severe Combined Immunodeficiency (SCID). In 2000, the first gene therapy "success" resulted in SCID patients with a functional immune system. These trials were stopped when it was discovered that two of ten patients in one trial had developed leukemia resulting from the insertion of the gene-carrying

Human Genetic Engineering – Methods

Human Genetic EngineeringSomaticSomatic genetic engineering involves adding genes to cells other than egg or sperm cells. For example, if a person had a disease caused by a defective gene, a healthy gene could be added to the affected cells to treat the disorder. As of now, this is likely to take the form of gene therapy. The distinguishing characteristic of somatic engineering is that it is

Cellulosic ethanol can considerably reduce gasoline use by 2030

As the debate on the future of cellulosic ethanol gains steam, a new study shows the U.S. can replace a third of its annual gasoline use with ethanol by 2030.

The study, jointly conducted by General Motors and Sandia National Laboratories, predicts that out of 90 billion gallons of ethanol that experts say need to be produced in 2030, 75 billion gallons could be cellulosic ethanol, which usually makes use of feedstock like corn-combs and switch grass.

A press release by Sandia National Laboratories says the study examined four sources of biofuels: agricultural residue, such as corn stover and wheat straw; forest residue; dedicated energy crop, including switch grass; and short rotation woody crops, such as willow and poplar trees. It found that the cost of producing, harvesting, storing and transporting these sources of cellulosic ethanol to newly built biorefineries was minimal and would not lead to a price hike of the final product.

“… an increase to 90 billion gallons of ethanol could be sustainably achieved by 2030 within real-world economic and environmental parameters,” says the study.

Reinforcing the argument that cellulosic ethanol could be produced in a sustainable way, the study notes that
“…large-scale cellulosic biofuel production could be achieved at or below current water consumption levels of petroleum fuels from on-shore oil production and refining.”

The study comes hot on the heels of another study, earlier released by the University of Minnesota, which shows cellulosic ethanol production contribute less to climate change compared to gasoline or even food crops-based ethanol.

 

 

 

 


Vilsack targeted for his Pro-GMOs stand

One day after President-Elect Barak Obama picked Iowa Governor, Tom Vilsack, as Agriculture Secretary, anti-biotechnology activists are out in full force trying to paint him as an apologist for the biotech industry. Tara Lohan in an article on Alternet.org declares Obama is sending to the United States Department of Agriculture (USDA) “…a pro-GMOs, pro-Biofuels Ag Secretary.”

 

Way back on November 12, when word went out that Obama planned to nominate Vilsack, the Organic Consumers Association (OCA) listed, on its website, six reasons why he’s inappropriate for the position.

 

Writing on the Nation, John Nichol quotes OCA as accusing Vilsack of having “…a glowing reputation as being a shill for agribusiness biotech giants like Monsanto.”

 

It’s interesting how anti-biotech groups malign anybody who’s supportive of crop genetic engineering, in total disregard of the nature of such support. Take the case of OCA. It’s quarrel with Vilsack stems from his support for Iowa farmers wanting to grow genetically modified foods. How can anybody expect him not to do that? He’s a Governor of a farm belt state, where life=farming and farming=life. Vilsack’s support for biotechnology has not been a blind one; it has been in the interest of farmers in his state. Well, for his efforts to help Iowa farmers to modernize their farming, he has won accolades from the Biotechnology Industry Organization. Farmers in Iowa will tell you he deserves it. Here is Iowa Corn Growers Association praise Vilsack’s appointment: In a press statement, the association said Vilsack had “…established an outstanding record here in Iowa as a capable, pragmatic leader who understood the importance of agriculture.” These are farmers speaking, not shills for Monsanto, DuPont, Syngenta or any other biotech corporation doing business in Iowa.

 

As Vilsack prepares to move to USDA, he should brace himself for sharper criticism for his stand on genetically modified organisms (GMOs). Governor Vilsack must not fear to stand for what’s right. He should stand his ground, especially when individuals or organizations attempt to contradict science. He shouldn’t lock out organizations such as OCA, the Greenpeace, Friends of the Earth and other entities opposed from agricultural biotechnology from the debate about genetically modified foods. But he must insist they stick to science to justify their opposition to GMOs. The same standards should apply to scientists and corporations advocating for genetically modified foods. They, too, have a duty to make a strong case for GMOs. They ought to educate the public about GMOs. It’s their baby, and they must tend to it.

Call for technology to produce cellulosic ethanol

Jean Bernick, the editor of Farm Journal Crops & Issues, is exhorting us “to talk trash.” Funny, isn’t it? Hold back though, because Bernick is not asking you to spite the vilest epithet at your opponent. No! She wants a discussion on how the corncob, that we normally consider trash, can effectively be used to produce cellulosic ethanol.

 

Bernick says there’s plenty of a corncob in cornfields, but, unfortunately, the agricultural machinery industry hasn’t found the technology to move it to biorefineries. Since”…cellulosic ethanol is around the corner”, Bernick wants the agricultural machinery industry to redouble efforts to find efficient technology to move corncob from the field without complicating the grain harvesting process.

 

It seems Bernick is not alone. The debate about the advantages of cellulosic ethanol is finding a life of its own. The North Dakota-based
Jamestown Sun today has an editorial on the future of the ethanol industry
. The editorial lists the challenges facing the ethanol industry. Particularly, it highlights the growing opposition toward food crops-based ethanol, and poses the question: Where should we be going with ethanol? Noting that environmentalists remain strongly opposed to food-crops-based ethanol, the editorial advises …where we would like to be going is to cellulosic ethanol, which uses nonfood crops such as switch grass, crop waste or material like wood chips as raw materials.”

 

Just like Bernick, Jamestown Sun, however,worries that the “…technology and industry aren’t there yet for commercial-scale cellulosic ethanol refining.” So, what’s the way forward? We all acknowledge times are difficult and that raising capital to develop new technologies for cellulosic ethanol refining is a hard nut to crack. The private sector can’t shoulder this burden alone. It needs help from the government. President-Elect Barack Obama has already pledged to pump money into the production of clean energy. Cellulosic ethanol is one of them. Giving the agricultural machinery industry a leg up, in the form of financial assistance, to produce cutting edge technology to produce cellulosic ethanol would definitely be a big milestone in making the U.S. energy independent.

Kenyan scientists weigh on GMOs

Scientists from one of Kenya’s premier university have endorsed crop genetic engineering. After a two-day workshop last week, University of Nairobi researchers dismissed fears that genetically modified organisms (GMOs) posed dangers to human health and the environment.

The scientists said although some caution was needed about GMOs, they had been found to be safe. They called on Kenya and other African countries to quickly enact biosafety laws that would allow their introduction.

Dr. John Nderitu, the Dean of College of Agriculture and Veterinary Services at the University of Nairobi likened GMOs to automobiles which he said if used badly could bring negative outcomes to the society. He said as long as there were biosafety laws to regulate GMOs, he saw nothing wrong in them.

The Kenyan scientists’ call could not have come at a better time. Debate on potential benefits of genetically modified foods, or lack of them, has been raging in Africa. Some anti-technology nongovernmental organizations, mostly based in developed countries, have literary camped in Africa to persuade governments there not to admit GMOs into their countries. This could be the reason why many African countries, except South Africa, continue to shun them. Countries such as Zambia and Zimbabwe have even passed laws to prohibit GMOs from their territories, which raises the question of whether they’d not like their scientists to study the potential of GMOs to agriculture. What’s these countries vision for innovative research if they can’t encourage their scientists to study GMOs?

Indian researcher makes a case for biotechnology

The journal Nature has published an article about how developing countries can make the best from biotech. Indira Nath, the article’s author, argues biotechnology can revolutionize food production and healthcare in developing countries only if these countries bolstered their scientific capacity.

 

Nath regrets intellectual property rights coupled with inhibit scientists from developing countries from accessing critical technologies. Further, the ongoing opposition to genetically modified foods in both developed and developing countries continues to stymie food production in the former countries.

 

To address this situation, Nath calls on governments in developing countries to intensify efforts in training researchers. They should also provide them with necessary technologies to do their work.

 

Nath joins a long list of scientists from developing countries calling on their governments to be more proactive promoting science and technology for sustainable development. Dr. Calestous Juma, a Kenyan scientist currently teaching at Harvard, has been another vocal supporter of biotechnology. Writing in Japan Times in July this year, Dr. Juma called on G-8 countries to encourage biotech cooperation in Africa. He cautioned that over-emphasis on biosafety was hindering many African countries from adopting biotechnology.

 

Nath and Dr. Juma make very strong cases for biotechnology. They are worth listening to.

Michigan smoothens the way for alternative energy investors

Michigan is about to enact a law to make readily available information on how to set up an alternative fuel production plant in the state.

 

The law, H.B. 5745 (PDF), requires the Department of Agriculture to publish, in plain language, all the procedures for “…preparing and executing applications and approvals necessary to establish an alternative fuels production facility in Michigan.”

 

The bill has already passed the Senate and House by wide margins. The law aims at boosting biodiesel and ethanol production in the state. Michigan must be commended for taking this bold step. Since information is power, setting up a one-stop shop for information on how to set up alternative fuel plants is perhaps the best way to attract investors to the Michigan.

 

Is the Federal government listening? It should follow in the footsteps of Michigan. President-Elect Barak Obama has already committed himself to increasing investment in alternative energy. Obama is on record as having said that “…embracing ethanol “ultimately helps our national security, because right now we’re sending billions of dollars to some of the most hostile nations on earth.” The President-Elect should reinforce his vow to help the ethanol industry by simplifying the regulatory regime. Ensuring potential investors in ethanol production have easily accessible information on how to set up production plants is the best assurance he can give them that he’s committed to their cause.

Link of ethanol use to high food prices questioned

As the debate on whether more ethanol use is sending food prices skyrocketing rages, the ethanol industry is positioning itself to set the record straight.

Four major players in the ethanol industry – Hawkeye, ICM, POET, and Green Plains Renewable Energy, Inc. (GPRE) – yesterday launched an organization called Growth Energy to promote the use of ethanol in a sustainable way. GrowthEnergy also plans to take head on “Big Food” for blaming the ethanol industry for high food prices.

In a press statement issued at the launch of GrowthEnergy, the heads of the four companies argued there was no link between ethanol use and food prices. “Big Food and their Washington lobbyists have been trying to blame the rising cost of food on American ethanol producers and the cost of corn. Well, now that the price of corn has dropped more than fifty percent since the summer, we ask the Big Food industry to explain to the American people why food prices are still so high,” said Jeff Broin, CEO of POET.

Dave Vander Griend, CEO of ICM pointed out that the price of corn had gone down by almost 50 per cent over the last few months yet food prices had not followed suit. “Our current low-priced corn, high-priced food economic situation shows that the experts were right - biofuels production does not lead to increased food costs,” said Griend.

With the launch of GrowthEnergy, it seems the war of words between ethanol producers and the food industry is likely ratchet up. GrowthEnergy is vowing to wage an intensive grassroots campaign to fight disinformation that more ethanol use leads to high food prices. It has already prepared a policy brief (PDF) on the issue, to bolster its argument.

EU challenges France on GM Maize

The European Union (EU) is again challenging France’s decision to ban a genetically modified (GM) maize developed by the U.S.-based biotech giant Monsanto. The European Food Safety Authority (EFSA) is angry that France has refused to allow the cultivation of MON 810, the only GM crop being grown in the European Union.

“No specific scientific evidence, in terms of risk to human and animal health and the environment, was provided that would justify the invocation of a safeguard clause,” EFSA said in an opinion article on its web site.

These are weighty words, coming especially from such a nonpartisan organization as EFSA. They’re words directed not only at France but other European countries weighing on the issue of genetically modified crops.

The issue of the safety of GM foods has been discussed since the introduction of the first genetically modified crop in 1996. Reputable organizations such as the World Health Organization (WHO) and the U.S. National Academies of Science have issued numerous reports on the safety of GM foods. In June 2005, for instance, WHO released a report entitled Modern Food Biotechnology, Human Health and Development, which reaffirmed the safety of GM foods. The U.S. National Academies of Science, itself, has on numerous occasions cautioned against condemning GM crops on the basis of non-scientific evidence.

France and other countries opposed to crop genetic engineering will do their citizens proud if they allow science to guide every decision of GM crops. Blanket condemnation of GM crops doesn’t serve the interests of farmers. It only denies them an opportunity to boost food production.

POET rolls out cellulosic ethanol plant

Cellulosic ethanol is on the move. Today, POET, the top U.S. ethanol producer, inaugurated a pilot cellulosic ethanol plant in South Dakota. The plant’s projected to churn out 22,000 gallons of cellulosic ethanol per year. POET has an amazing, professionally done documentary that takes you, step-by-step, along the journey cellulosic ethanol has followed. It’s available here.

In the press release it issued today to announce the start of the plant’s operations, POET said in 2011, it will roll out a $200 million commercial-scale cellulosic plant in Iowa.

Today’s announcement, of course, is a major development and a big leap to energy independence. More good news is that cellulosic ethanol utilizes non-food crops; so there’ll not be politicking that food security will be compromised. A lot of politics continues to dog food-crops-based ethanol. There are those who claim that diverting food crops, such as corn, to ethanol production is to blame for the current food shortages. There are others who dismiss such an argument as baseless and not supported by facts. Whatever the merits or demerits of using food-crops to make ethanol, POET is demonstrating that the journey to reliable and clean energy is unstoppable.

There’s every reason to cheer up POET, and of course the Federal government, which provided seed money for research. Renewable sources of energy, such as cellulosic ethanol, hold the key to energy independence. President-Elect Baraka Obama, for instance, has said as much on the issue. He has promised massive investments into the next generation of biofuels. POET and other companies in the biofuels business have no excuse of not doubling efforts to produce biofuels. Political will is already there; it’s up to them to exploit it.

There’s a bright future for cellulosic ethanol investment

These are tough times for everybody, including the biofuels industry. The Associated Press has an interesting article about how corn-based ethanol producers are literally struggling to stay afloat. The article notes how shares of leading ethanol producers in the country, such as Aventine Renewable Energy Holdings Inc., Pacific Ethanol Inc. and BioFuel Energy Corp, lost about 95 per cent of their value in 2008. Volatility in prices of corn, the article observes, is mainly to blame.

The article argues the future lies in cellulosic ethanol, but cautions that capital might prove hard to obtain from Wall Street due to the fact that cellulosic industry is still “…experimenting with a broad range of feedstocks….” Well, this is well founded fear, which the cellulosic industry should see as an opportunity and not a threat to their existence. Innovations such as cellulosic ethanol are fraught with anxiety and uncertainty, but such should not be an excuse to stymie progress. The world’s thirst for energy is unquenchable, and every effort will be needed to seek alternative sources of energy such as cellulosic ethanol. Cellulosic ethanol is clean and its production poses little or no threat to the environment.

Research into feedstocks that can be used to produce cellulosic ethanol needs to be intensified. Currently, the raw material of choice to cellulosic ethanol producers is corn cobs. Switch grass is another raw material that’s fast gaining currency in the biofuels industry.

There’s a lot of support for cellulosic ethanol, in form of financial incentives for research and development, and political goodwill, coming from the government. The industry has a friend in President Barak Obama, who has made a personal commitment to invest in new generation clean energy such as cellulosic ethanol. The Associated Press article notes that the Department of Energy in 2007 awarded $385 million to six companies to conduct research and build biomass-to-fuel plants. The Obama administration is likely to increase investment in cellulosic ethanol production.

The current efforts to shore up cellulosic ethanol seem to be bearing fruits. As I noted in an earlier blog post, POET LLC is operating a pilot biorefinery in Scotland, South Dakota. If everything goes well, the company plans to roll out a $200 million cellulosic ethanol refinery Emmetsburg, Iowa, in 2011. And there are more players willing to jump into the bandwagon. They ought not be discouraged to do so. Demand for energy is ever increasing, and whoever invests in cellulosic ethanol will not regret.